Erratum to: JOTROL, a Novel Formulation of Resveratrol, Shows Beneficial Effects in the 3xTg-AD Mouse Model

[Journal of Alzheimer’s Disease, 86(1) (2022), 173–190, 10.3233/JAD-215370] https://doi.org/10.3233/JAD-215370.

When this article was first published, the name of one of the authors was missing from the list of authors. The online version has been updated to include the author Farzaneh Modarresi. All co-authors are in agreement with this correction.

Therefore, the correct updated list of authors and their affiliation is:

Jessica L. Dennison^a,b, Claude-Henry Volmar^a,b, Farzaneh Modarresi^a,b, Danbing Ke^c, James Wang^c, Emilie Gravel^d, Sabrina Hammond-Vignini^d, Zuomei Li^d, James A. Timmons^e, Ines Lohse^a,b, Marshall A. Hayward^f, Shaun P. Brothers^a,b and Claes Wahlestedt^a,b

^aDepartment of Psychiatry & Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, USA

^bCenter for Therapeutic Innovation, University of Miami Miller School of Medicine, Miami, FL, USA

^cKDM Laboratories Inc., Montreal, QC, Canada

^dNuChem Sciences Inc., St. Laurent, QC, Canada

^eAugur Precision Medicine LTD, Stirling, UK

^fJupiter Neurosciences, Inc. Jupiter, FL, USA